{"id":"https://openalex.org/W2157354650","doi":"https://doi.org/10.1111/dom.12286","title":"The effect of addition of liraglutide to high\u2010dose intensive insulin therapy: a randomized prospective trial","display_name":"The effect of addition of liraglutide to high\u2010dose intensive insulin therapy: a randomized prospective trial","alternate_titles":[],"publication_year":2014,"publication_date":"2014-03-25","ids":{"openalex":"https://openalex.org/W2157354650","doi":"https://doi.org/10.1111/dom.12286","mag":"2157354650","pmid":"https://pubmed.ncbi.nlm.nih.gov/24589127"},"language":"en","primary_location":{"id":"doi:10.1111/dom.12286","doi":"https://doi.org/10.1111/dom.12286","is_oa":false,"landing_page_url":"https://doi.org/10.1111/dom.12286","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2157354650"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073112110","display_name":"Wendy S. Lane","orcid":"https://orcid.org/0000-0002-4317-9106","observed_orcids":["https://orcid.org/0000-0002-4317-9106"]},"institutions":[{"id":"https://openalex.org/I4210159096","display_name":"Mountain Diabetes and Endocrine Center","ror":"https://ror.org/04zdc2070","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210159096"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"W. Lane","raw_affiliation_strings":["Mountain Diabetes and Endocrine Center, Asheville, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mountain Diabetes and Endocrine Center, Asheville, NC, USA","institution_ids":["https://openalex.org/I4210159096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012426357","display_name":"Stephen L. Weinrib","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159096","display_name":"Mountain Diabetes and Endocrine Center","ror":"https://ror.org/04zdc2070","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210159096"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. Weinrib","raw_affiliation_strings":["Mountain Diabetes and Endocrine Center, Asheville, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mountain Diabetes and Endocrine Center, Asheville, NC, USA","institution_ids":["https://openalex.org/I4210159096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004791016","display_name":"Jonathan M. Rappaport","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159096","display_name":"Mountain Diabetes and Endocrine Center","ror":"https://ror.org/04zdc2070","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210159096"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. Rappaport","raw_affiliation_strings":["Mountain Diabetes and Endocrine Center, Asheville, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mountain Diabetes and Endocrine Center, Asheville, NC, USA","institution_ids":["https://openalex.org/I4210159096"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015134345","display_name":"Christopher B. Hale","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159096","display_name":"Mountain Diabetes and Endocrine Center","ror":"https://ror.org/04zdc2070","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210159096"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C. Hale","raw_affiliation_strings":["Mountain Diabetes and Endocrine Center, Asheville, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mountain Diabetes and Endocrine Center, Asheville, NC, USA","institution_ids":["https://openalex.org/I4210159096"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5073112110"],"corresponding_institution_ids":["https://openalex.org/I4210159096"],"apc_list":{"value":5380,"currency":"USD","value_usd":5380},"apc_paid":null,"fwci":7.3924,"has_fulltext":false,"cited_by_count":95,"citation_normalized_percentile":{"value":0.9797475,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"16","issue":"9","first_page":"827","last_page":"832"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.004100000020116568,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/liraglutide","display_name":"liraglutide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8659999966621399},{"id":"https://openalex.org/keywords/intensive-insulin-therapy","display_name":"intensive insulin therapy","score":0.9079999923706055},{"id":"https://openalex.org/keywords/multiple-daily-injections","display_name":"multiple daily insulin injections","score":0.9010000228881836},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.949999988079071},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.7789999842643738},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.7099999785423279},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.8659999966621399},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.7919999957084656},{"id":"https://openalex.org/keywords/glycemic-variability","display_name":"glycemic variability","score":0.9729999899864197},{"id":"https://openalex.org/keywords/continuous-glucose-monitoring","display_name":"continuous glucose monitoring","score":0.8119999766349792},{"id":"https://openalex.org/keywords/insulin-dose-reduction","display_name":"insulin dose reduction","score":0.7279999852180481},{"id":"https://openalex.org/keywords/continuous-subcutaneous-insulin-infusion","display_name":"insulin pump therapy","score":0.8190000057220459},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.8949999809265137}],"concepts":[{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.8745232820510864},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.8514196276664734},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8459327220916748},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6479232907295227},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5918494462966919},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.514188289642334},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5040475726127625},{"id":"https://openalex.org/C43376680","wikidata":"https://www.wikidata.org/wiki/Q6580786","display_name":"Bolus (digestion)","level":2,"score":0.4359932243824005}],"mesh":[{"descriptor_ui":"D000069450","descriptor_name":"Liraglutide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000069450","descriptor_name":"Liraglutide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006943","descriptor_name":"Hyperglycemia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006943","descriptor_name":"Hyperglycemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015992","descriptor_name":"Body Mass Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/dom.12286","doi":"https://doi.org/10.1111/dom.12286","is_oa":false,"landing_page_url":"https://doi.org/10.1111/dom.12286","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmid:24589127","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24589127","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320322436","display_name":"Novo Nordisk","ror":"https://ror.org/0435rc536"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W1967256054","https://openalex.org/W1975791875","https://openalex.org/W1977102586","https://openalex.org/W1980022623","https://openalex.org/W1996796525","https://openalex.org/W2002908162","https://openalex.org/W2004456679","https://openalex.org/W2008153537","https://openalex.org/W2039883842","https://openalex.org/W2060773808","https://openalex.org/W2061549173","https://openalex.org/W2081510795","https://openalex.org/W2103023541","https://openalex.org/W2126095744","https://openalex.org/W2127833912","https://openalex.org/W2160274347","https://openalex.org/W2169669759"],"related_works":["https://openalex.org/W2415124771","https://openalex.org/W1981649985","https://openalex.org/W2002908162","https://openalex.org/W2899237794","https://openalex.org/W3121084704","https://openalex.org/W2163303750","https://openalex.org/W2140872425","https://openalex.org/W2121073500","https://openalex.org/W2337735601","https://openalex.org/W2185178624"],"abstract_inverted_index":{"AIMS:":[0],"Patients":[1],"with":[2,79,87,98,122,161,199,226],"type":[3,88,99],"2":[4,89,100],"diabetes":[5,90,101],"and":[6,150,189,232],"insulin":[7,12,28,35,53,76,81,93,106,113,133,137,163,168,179,187,204,213,223],"resistance":[8],"may":[9],"require":[10],"high":[11],"doses":[13],"to":[14,26,33,50,73,128,152,209],"control":[15,201,221],"hyperglycaemia.":[16],"The":[17,43],"addition":[18,70],"of":[19,45,68,71,105,229],"glucagon-like":[20],"peptide-1":[21],"receptor":[22],"agonists":[23],"(GLP-1":[24],"RAs)":[25],"basal":[27],"therapy":[29,48,54,77,214,224],"has":[30,55],"been":[31,57],"shown":[32],"reduce":[34],"requirement":[36],"while":[37],"reducing":[38],"insulin-associated":[39],"weight":[40,230],"gain":[41],"[1,2].":[42],"effect":[44,67],"GLP-1":[46],"RA":[47],"added":[49],"intensive":[51,75,136,162,167,210],"(basal/bolus)":[52,212],"not":[56],"studied":[58],"in":[59,83,159,184,216,219],"a":[60],"prospective":[61],"trial.":[62],"This":[63],"trial":[64],"evaluated":[65],"the":[66,69,200],"liraglutide":[72,131,177,208],"high-dose":[74,92,211],"compared":[78,198],"standard":[80],"up-titration":[82,169],"obese":[84],"insulin-resistant":[85],"patients":[86],"requiring":[91,102],"therapy.":[94,164],"METHODS:":[95],"Thirty-seven":[96],"subjects":[97,175],">100":[103],"units":[104],"daily":[107,119,158],"administered":[108],"either":[109,130,153],"by":[110,117,193],"continuous":[111,194],"subcutaneous":[112],"infusion":[114],"(CSII)":[115],"or":[116,123,135,155],"multiple":[118],"injections":[120],"(MDIs)":[121],"without":[124],"metformin":[125],"were":[126],"randomized":[127],"receive":[129],"plus":[132,178],"(LIRA)":[134],"only":[138],"(controls).":[139],"Liraglutide":[140],"was":[141],"initiated":[142],"at":[143],"0.6":[144],"mg":[145,157],"subcutaneously":[146],"(sq)":[147],"per":[148],"day":[149],"increased":[151],"1.2":[154],"1.8":[156],"combination":[160],"Controls":[165],"received":[166],"only.":[170,205],"RESULTS:":[171],"At":[172],"6":[173],"months,":[174],"receiving":[176,203],"experienced":[180],"statistically":[181],"significant":[182],"reductions":[183],"HbA1c,":[185],"weight,":[186],"dose":[188],"glycaemic":[190,220],"variability":[191],"(GV)":[192],"glucose":[195],"monitor":[196],"(CGM)":[197],"group":[202],"CONCLUSIONS:":[206],"Adding":[207],"results":[215],"greater":[217],"improvement":[218],"than":[222],"alone,":[225],"additional":[227],"benefits":[228],"loss":[231],"reduced":[233],"GV.":[234]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2157354650","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":11},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":14},{"year":2018,"cited_by_count":10},{"year":2017,"cited_by_count":15},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":8}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
